These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1095 related items for PubMed ID: 17926652

  • 1. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [Abstract] [Full Text] [Related]

  • 2. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
    Steel A, John L, Shamji MH, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.
    HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
    [Abstract] [Full Text] [Related]

  • 3. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
    Benito JM, Lopez M, Lozano S, Ballesteros C, Capa L, Martinez P, Gonzalez-Lahoz J, Soriano V.
    J Infect Dis; 2005 Dec 15; 192(12):2142-6. PubMed ID: 16288380
    [Abstract] [Full Text] [Related]

  • 4. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E, Al Tabaa Y, Baillat V, Segondy M, Picot MC, Reynes J, Vendrell JP.
    Cytometry B Clin Cytom; 2009 Jul 15; 76(4):249-60. PubMed ID: 19072838
    [Abstract] [Full Text] [Related]

  • 5. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M, Cordero M, Almeida J, Orfao A.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):22-33. PubMed ID: 17051525
    [Abstract] [Full Text] [Related]

  • 6. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec 15; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 7. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S, QUEST Study Group.
    Clin Infect Dis; 2007 Aug 01; 45(3):381-90. PubMed ID: 17599319
    [Abstract] [Full Text] [Related]

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 9. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
    Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K.
    AIDS; 2006 Apr 04; 20(6):813-20. PubMed ID: 16549964
    [Abstract] [Full Text] [Related]

  • 10. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA.
    AIDS; 2008 Oct 01; 22(15):1937-41. PubMed ID: 18784457
    [Abstract] [Full Text] [Related]

  • 11. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O, Holub M, Spála J, Kalanin J, Stanková M.
    Acta Virol; 2003 Oct 01; 47(2):121-4. PubMed ID: 14524479
    [Abstract] [Full Text] [Related]

  • 12. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA.
    AIDS; 2007 Jul 31; 21(12):1525-34. PubMed ID: 17630546
    [Abstract] [Full Text] [Related]

  • 13. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
    Mohey R, Jørgensen LB, Møller BK, Black FT, Kjems J, Obel N.
    J Clin Virol; 2005 Dec 31; 34(4):257-67. PubMed ID: 16286049
    [Abstract] [Full Text] [Related]

  • 14. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF, Price P, French MA.
    HIV Med; 2005 Jul 31; 6(4):278-83. PubMed ID: 16011533
    [Abstract] [Full Text] [Related]

  • 15. RANTES production by T cells and CD8-mediated inhibition of human immunodeficiency virus gene expression before initiation of potent antiretroviral therapy predict sustained suppression of viral replication.
    Fransen S, Copeland KF, Smieja M, Smaill F, Rosenthal KL.
    J Infect Dis; 2000 Feb 31; 181(2):505-12. PubMed ID: 10669333
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327
    [Abstract] [Full Text] [Related]

  • 17. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I.
    Clin Infect Dis; 2008 Jun 15; 46(12):1902-10. PubMed ID: 18462177
    [Abstract] [Full Text] [Related]

  • 18. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    Eggena MP, Barugahare B, Okello M, Mutyala S, Jones N, Ma Y, Kityo C, Mugyenyi P, Cao H.
    J Infect Dis; 2005 Mar 01; 191(5):694-701. PubMed ID: 15688282
    [Abstract] [Full Text] [Related]

  • 19. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
    Papasavvas E, Sandberg JK, Rutstein R, Moore EC, Mackiewicz A, Thiel B, Pistilli M, June RR, Jordan KA, Gross R, Maino VC, Nixon DF, Montaner LJ.
    J Infect Dis; 2003 Sep 15; 188(6):873-82. PubMed ID: 12964119
    [Abstract] [Full Text] [Related]

  • 20. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 15; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.